• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Haemodialysis is recommended for acute salicylate poisoning

, 26 August 2020/in E-News /by 3wmedia

The best remedy for severe salicylate poisoning is haemodialysis, according to a comprehensive systematic review of the medical literature.  Salicylate is an active ingredient in aspirin as well as hundreds of over-the-counter medications, and contributes to approximately 20,000 accidental or intentional poisonings and nearly 30 deaths reported to US Poison Control Centers every year.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:33Haemodialysis is recommended for acute salicylate poisoning

Prolonged statin use may lower risk of lung cancer death

, 26 August 2020/in E-News /by 3wmedia

Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease, according to a study.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:41Prolonged statin use may lower risk of lung cancer death

Tubal ligation may improve the prognosis of endometrial cancer later in life

, 26 August 2020/in E-News /by 3wmedia

Endometrial cancer (EC) can spread by several routes, including the lymph system, blood vessels, through the uterine wall, as well as through the fallopian tubes into the peritoneal cavity, but the association of transtubal dissemination of EC with cancer stage, histological type, and mortality is unknown. However, according to a study women who have undergone a tubal ligation (TL) and develop more aggressive types of EC may have lower mortality. The authors postulate that women who have had TL have reduced passage of cancer cells through the fallopian tubes, thus lowering disease stage, which is a strong prognostic factor.

To investigate the possible relationship between TL and EC outcomes, Ashley Felix, Ph.D., of the Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics and Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, and colleagues analyzed data from the multi-institutional NRG Oncology/Gynecologic Oncology Group 210 trial conducted between September 2003 and December 2011. They assessed the history and outcomes for 4489 women diagnosed with EC, including TL, stage, metastasis, and mortality.

About 28% of the women reported having TL at a median age of 32 years. The researchers found that EC patients who also had TL were less likely to have stage III or IV EC across all subtypes of the disease. They were also less likely to have peritoneal metastasis, even if they had more aggressive EC types (high-grade endometrial or serous carcinoma). Metastases to the fallopian tubes, ovaries, parametrium, and bladder/bowel were also inversely associated with TL. However, when adjusted for stage, TL was not associated with disease-specific or overall mortality, except for clear cell EC. This suggests that the mortality benefit was related to inhibiting dissemination of cancer cells through the fallopian tubes.

A limitation of the study, Felix et al. note, is lack of information on types of TL procedures, which have changed over time. Newer methods such as mechanical clips or tubal implants may have a different effect from older ones such as partial excision of tubal segments. However, the authors write that ‘…our study provides evidence that transtubal spread is an important mechanism of metastasis for aggressive histological types of endometrial carcinoma and that this process can be inhibited by TL.’ EurekAlert

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:28Tubal ligation may improve the prognosis of endometrial cancer later in life

Portable stimulator being tested on Parkinson patients

, 26 August 2020/in E-News /by 3wmedia

Researchers at the Sahlgrenska Academy have shown that a weak electric

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:36Portable stimulator being tested on Parkinson patients

Study finds no harm from hospital policies that let families observe CPR

, 26 August 2020/in E-News /by 3wmedia

When a hospital patient

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:43Study finds no harm from hospital policies that let families observe CPR

HIV prevention study demonstrates sustained benefit of early antiretroviral therapy

, 26 August 2020/in E-News /by 3wmedia

Antiretroviral therapy (ART) for HIV infection provides lasting protection against the sexual transmission of the virus from infected men and women to their HIV-uninfected sexual partners, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada. The study, known as HPTN 052, began in 2005 and enrolled 1,763 HIV sero-discordant couples

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:23HIV prevention study demonstrates sustained benefit of early antiretroviral therapy

Removing more tissue during breast cancer surgery reduces by half the need for second procedure

, 26 August 2020/in E-News /by 3wmedia

Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study.

Nearly 300,000 women in the United States are diagnosed with breast cancer each year; more than half undergo breast-conserving surgery with a partial mastectomy to remove the disease. However, between 20% and 40% of patients who undergo this procedure have

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:31Removing more tissue during breast cancer surgery reduces by half the need for second procedure

Growing a blood vessel in a week

, 26 August 2020/in E-News /by 3wmedia

The technology for creating new tissues from stem cells has taken a giant leap forward. Two tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown in a new study from Sahlgrenska Acadedmy and Sahlgrenska University Hospital.
Just three years ago, a patient at Sahlgrenska University Hospital received a blood vessel transplant grown from her own stem cells.
Suchitra Sumitran-Holgersson, Professor of Transplantation Biology at Sahlgrenska Academy, and Michael Olausson, Surgeon/Medical Director of the Transplant Center and Professor at Sahlgrenska Academy, came up with the idea, planned and carried out the procedure. Professors Sumitran-Holgersson and Olausson have published a new study based on two other transplants that were performed in 2012 at Sahlgrenska University Hospital. The patients, two young children, had the same condition as in the first case

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:38Growing a blood vessel in a week

A lightweight, portable system to produce the gas nitric oxide from the air

, 26 August 2020/in E-News /by 3wmedia

Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:26A lightweight, portable system to produce the gas nitric oxide from the air

Livers donated after cardiac death safe to use in liver cancer patients

, 26 August 2020/in E-News /by 3wmedia

Patients with liver cancer can be cured with a liver transplant. But because of the shortage of donated organs, these patients often die waiting for a liver. That

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:33Livers donated after cardiac death safe to use in liver cancer patients
Page 137 of 231«‹135136137138139›»

Latest issue of International Hospital

April 2024

3 July 2025

EEG-powered brain computer interface enables finger-level robotic hand control

2 July 2025

Scientists identify ‘traumome’ targets for rapid emergency trauma treatment

1 July 2025

BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription